Akari Therapeutics AKTX Balance Sheet (2011-2026)

NASDAQ AKTX
$7.94 +0.15 (+1.96%)
As of: Aug 21, 2026 · 9:43 AM EDT
Balance Sheet Dec2011 Dec2012 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation (Quarter)
0.16M
Receivables - Accured (Quarter)
Assets
Current Assets
Cash & Equivalents (Quarter)
12.32M14.06M3.79M9.36M8.15M13.25M7.20M3.85M1.31M4.18M2.25M2.66M2.64M2.77M0.16M5.26M2.83M7.75M
Receivables - Net (Quarter)
Receivables - Other (Quarter)
Receivables (Quarter)
Prepaid Assets (Quarter)
1.35M0.29M1.01M2.17M3.09M0.47M0.63M0.30M1.23M0.81M0.40M0.20M0.63M0.45M0.35M0.18M0.73M0.53M
Current Assets (Quarter)
13.67M14.58M4.80M11.63M11.35M13.81M8.00M4.34M2.77M5.08M2.73M2.95M3.35M3.30M2.95M5.46M3.59M8.32M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
Goodwill (Quarter)
8.43M8.43M8.43M8.43M8.43M
Intangibles (Quarter)
0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.01M39.18M39.18M39.18M34.00M34.00M30.30M30.30M
Goodwill & Intangibles (Quarter)
0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.01M39.18M47.61M47.61M34.00M42.43M38.73M38.73M
Long-Term Deferred Tax (Quarter)
34.62M42.24M
Other Non-Current Assets (Quarter)
0.06M0.06M0.06M0.06M0.06M0.06M0.06M
Non-Current Assets (Quarter)
0.03M0.03M0.03M0.02M0.02M0.02M0.02M0.01M47.61M47.61M47.61M42.43M42.43M30.30M30.30M
Assets (Quarter)
13.69M14.60M4.83M11.65M11.37M13.83M8.01M4.36M2.77M5.08M2.73M50.56M50.96M50.91M45.38M47.89M33.89M38.62M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
2.41M3.38M1.69M1.79M1.63M0.95M1.03M1.67M3.21M4.69M4.78M12.41M13.07M11.61M10.84M8.77M8.64M9.40M
Notes Payables (Quarter)
0.66M0.23M0.18M0.20M0.08M0.05M
Payables (Quarter)
2.41M3.38M1.69M1.79M1.63M0.95M1.03M1.67M3.21M4.69M4.78M13.07M13.29M11.79M11.04M8.85M8.69M9.40M
Accumulated Expenses (Quarter)
0.98M1.84M1.56M3.18M1.41M3.15M2.40M1.57M1.53M1.69M2.60M3.14M3.49M2.47M1.62M2.34M3.33M3.51M
Other Accumulated Expenses (Quarter)
0.13M0.09M0.09M0.98M0.65M0.32M0.73M0.80M0.65M0.48M0.45M0.70M0.58M
Total Current Liabilities (Quarter)
4.58M6.33M8.78M9.43M19.91M20.91M17.14M15.57M12.35M13.41M13.94M
Non-Current Liabilities
Non-Current Debt (Quarter)
1.65M0.70M0.70M0.10M
Convertible Debt (Quarter)
0.70M0.70M0.70M0.66M0.67M0.68M0.69M
Non-Current Deferred Tax Liability (Quarter)
8.04M8.04M8.04M6.95M6.95M6.09M6.09M
Other Non-Current Liabilities (Quarter)
7.85M1.70M1.25M0.10M0.10M0.10M0.38M0.27M0.13M0.10M0.23M0.02M0.12M
Total Non-Current Liabilities (Quarter)
4.19M3.53M3.33M2.67M4.98M2.63M27.95M28.95M25.18M22.59M19.33M19.49M19.91M
Total Liabilities (Quarter)
6.75M5.22M3.24M6.09M3.05M12.04M5.23M4.58M2.77M5.08M2.73M28.33M29.21M25.31M22.69M19.56M19.51M20.03M
Shareholder's Equity
Total Debt (Quarter)
1.65M0.70M0.70M0.10M
Common Equity (Quarter)
6.95M9.38M1.59M5.55M8.33M1.79M6.56M2.78M0.21M-0.23M-3.55M-3.70M-6.69M22.23M21.75M25.61M22.69M28.33M14.38M18.59M
Liabilities and Shareholders Equity (Quarter)
13.69M14.60M4.83M11.65M11.37M13.83M8.01M4.36M2.77M5.08M2.73M50.56M50.96M50.91M45.38M47.89M33.89M38.62M
Retained Earnings (Quarter)
-175.47M-0.65M-192.47M-199.71M-210.56M-217.45M-220.50M-227.46M-233.03M-240.60M-243.50M-247.25M-251.00M-252.90M-259.30M-264.55M-279.00M-283.81M
Treasury Shares (Quarter)
21.48M21.48M418.58M385.95M288.38M251.82M251.82M0.00M